About multiple sclerosis, natalizumab, and CD34+ hematopoietic progenitors

被引：2
|
作者：
Vuillat, Carine [1 ]
Androdias, Geraldine [1 ]
Davoust, Nathalie [1 ]
Nataf, Serge [1 ]
机构：
[1] INSERM, U842, F-69372 Lyon, France
来源：
BLOOD | 2008年 / 112卷 / 01期
关键词：
D O I：
10.1182/blood-2008-04-150813
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：208 / 209
页数：2
相关论文
共 50 条
  • [1] More about multiple sclerosis, natalizumab, and CD34+ hematopoietic progenitors -: Response
    Bonig, Halvard
    Wundes, Annette
    Papayannopoulou, Thalia
    BLOOD, 2008, 112 (01) : 209 - 210
  • [2] Natalizumab and Impedance of the Homing of CD34+ Hematopoietic Progenitors
    Saure, Christian
    Warnke, Clemens
    Zohren, Fabian
    Schroeder, Thomas
    Bruns, Ingmar
    Cadeddu, Ron P.
    Weigelt, Christian
    Fischer, Ute
    Kobbe, Guido
    Hartung, Hans-Peter
    Adams, Ortwin
    Kieseier, Bernd C.
    Haas, Rainer
    ARCHIVES OF NEUROLOGY, 2011, 68 (11) : 1428 - 1431
  • [3] Mobilization of CD34+ myeloid progenitors in the blood of multiple sclerosis patients
    Nataf, S.
    Reynaud, E.
    Androdias, G.
    Maicus, C.
    Belin, M. F.
    Confavreux, C.
    Vuaillat, C.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 195 - 196
  • [4] SELECTION OF CD34+ HEMATOPOIETIC PROGENITORS BY MAGNETIC IMMUNOADSORPTION
    CANCELAS, JA
    QUEROL, S
    CANALS, C
    TUQUES, D
    PETRIZ, J
    AMILL, B
    GARCIALOPEZ, J
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 755 - 755
  • [5] JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab
    Frohman, Elliot M.
    Monaco, Maria Chiara
    Remington, Gina
    Ryschkewitsch, Caroline
    Jensen, Peter N.
    Johnson, Kory
    Perkins, Molly
    Liebner, Julia
    Greenberg, Benjamin
    Monson, Nancy
    Frohman, Teresa C.
    Douek, Daniel
    Major, Eugene O.
    JAMA NEUROLOGY, 2014, 71 (05) : 596 - 602
  • [6] No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients
    Lutterotti, A.
    Jelcic, I.
    Schulze, C.
    Schippling, S.
    Breiden, P.
    Mazzanti, B.
    Reinhardt, S.
    DiGioia, M.
    Repice, A.
    Massacesi, L.
    Sputtek, A.
    Salinas-Riester, G.
    Kroeger, N.
    Sospedra, M.
    Saccardi, R.
    Zander, A.
    Martin, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (08) : 1188 - 1192
  • [7] Natalizumab-induced mobilization of CD34+ hematopoietic progenitor cells -: Response
    Zohren, Fabian
    BLOOD, 2008, 112 (01) : 210 - 210
  • [8] Effects of chemokines on CD34+ progenitors
    Liesveld, JL
    Rosell, KE
    Belanger, TJ
    Harbol, AL
    Panoskaltsis, N
    Abboud, CN
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 729 - 729
  • [9] HIV-1-related mechanisms of suppression of CD34+ hematopoietic progenitors
    Zauli, G
    Capitani, S
    PATHOBIOLOGY, 1996, 64 (01) : 53 - 58
  • [10] Description of a new antigen family expressed on CD34+ hematopoietic progenitors.
    Lopez, M
    Humeau, L
    Jordier, F
    Bardin, F
    Alario, T
    Sempere, C
    Coulombel, L
    Chabannon, C
    Dubreuil, P
    TISSUE ANTIGENS, 1996, 48 (4-II): : MC403 - MC403
12345